Dr. Clement C. Yang, MD

Dr. Yang practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Yang's NPI, 1336151570, was assigned on August 13, 2006. Dr. Yang graduated from Icahn School Of Medicine At Mount Sinai in 1988. Dr. Yang holds California license G66368.

Dr. Yang's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Yang's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Yang to 2 more home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yang is board certified in internal medicine by the American Board of Internal Medicine. Dr. Yang is licensed in California.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, aneurysm, ankle or foot injury, aortic atherosclerois, arthritis and asthma among the conditions Dr. Yang treats.

CMS data shows 910 Medicare services from Dr. Yang across 15 procedure codes in 2024, for 112 Medicare patients. Medicare paid $59,920 for them. Every service was in an office.

CMS counts 112 Medicare patients who saw Dr. Yang in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 72, with 40% women.

In 2024, Dr. Yang wrote 1,328 Medicare Part D claims for 117 patients. 88% of them were for generic drugs. CMS names the drug for 914 of them, across 36 drugs with 11 or more claims each, at $73,513 in total drug cost. In 2023, CMS named 720 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Yang for performance year 2024, reported as part of a group. Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yang as offering telehealth.

CMS Open Payments shows 16 general payments to Dr. Yang from 7 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 85% of the total. Gilead Sciences, Inc. paid the most, $2,859.

Dmand AI lists 1 award for Dr. Yang, most recently CMS Stage 1 EHR in 2013.

Dr. Yang graduated from Icahn School Of Medicine At Mount Sinai in 1988.

Dr. Yang is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.